Your browser doesn't support javascript.
loading
PROTAC-Design-Evaluator (PRODE): An Advanced Method for In-Silico PROTAC Design.
A S, Ben Geoffrey; Agrawal, Deepak; Kulkarni, Nagaraj M; Vetrivel, Rajappan; Gurram, Kishan.
Afiliación
  • A S BG; Sravathi AI Technology Pvt. Ltd., 63-B, Bommasandra Industrial Area, Bengaluru, Karnataka 560099, India.
  • Agrawal D; Sravathi AI Technology Pvt. Ltd., 63-B, Bommasandra Industrial Area, Bengaluru, Karnataka 560099, India.
  • Kulkarni NM; Sravathi AI Technology Pvt. Ltd., 63-B, Bommasandra Industrial Area, Bengaluru, Karnataka 560099, India.
  • Vetrivel R; Sravathi AI Technology Pvt. Ltd., 63-B, Bommasandra Industrial Area, Bengaluru, Karnataka 560099, India.
  • Gurram K; Sravathi AI Technology Pvt. Ltd., 63-B, Bommasandra Industrial Area, Bengaluru, Karnataka 560099, India.
ACS Omega ; 9(11): 12611-12621, 2024 Mar 19.
Article en En | MEDLINE | ID: mdl-38524483
ABSTRACT
PROTAC (proteolysis-targeting chimeras) is a rapidly evolving technology to target undruggable targets. The mechanism by which this happens is when a bifunctional molecule binds to a target protein and also brings an E3 ubiquitin ligase in proximity to trigger ubiquitination and degradation of the target protein. Yet, in-silico-driven approaches to design these heterobifunctional molecules that have the desired functional properties to induce proximity between the target protein and E3 ligase remain to be established. In this paper, we present a novel in-silico method for PROTAC design and to demonstrate the validity of our approach, we show that for a BRD4-VHL-PROTAC-mediated ternary complex known in the literature, we are able to reproduce the PROTAC binding mode, the structure of the ternary complex formed therein, and the free energy (ΔG) thermodynamics favoring ternary complexation through theoretical/computational methodologies. Further, we demonstrate the use of thermal titration molecule dynamics (TTMD) to differentiate the stability of PROTAC-mediated ternary complexes. We employ the proposed methodology to design a PROTAC for a new system of FGFR1-MDM2 to degrade the FGFR1 (fibroblast growth factor receptor 1) that is overexpressed in cancer. Our work presented here and named as PROTAC-Designer-Evaluator (PRODE) contributes to the growing literature of in-silico approaches to PROTAC design and evaluation by incorporating the latest in-silico methods and demonstrates advancement over previously published PROTAC in-silico literature.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Omega Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Omega Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA